Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?

Author: CesaClaudia Ciceri, PellandaLucia Campos, PortalVera Lucia, RadaelliGraciane, SausenGrasiele

Paper Details 
Original Abstract of the Article :
BACKGROUND: Long-term safety, effectiveness and criteria for treatment with statins in children are still unclear in clinical practice. There is very limited evidence for the use of medication to treat children with dyslipidemia secondary to obesity who do not respond well to lifestyle modification....See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173338/

データ提供:米国国立医学図書館(NLM)

Statins and Obese Children: A Need for More Research

[Dyslipidemia], a condition characterized by abnormal lipid levels in the blood, can be a concern for both children and adults. This study specifically explores the use of [statins] to treat [secondary dyslipidemia] in [obese children]. Imagine a desert oasis where the water source is polluted – that's what dyslipidemia is like, disrupting the body's delicate balance.

Statins: A Limited Evidence Base for Obese Children

The study, a [systematic review], highlights the lack of conclusive evidence supporting the use of [statins] for treating [dyslipidemia] in [obese children]. The researchers found no randomized clinical trials specifically addressing this issue, emphasizing the need for further research in this area. It's like a desert traveler needing to find a reliable source of clean water – more research is needed to determine the effectiveness and safety of statins for this specific population.

Navigating Dyslipidemia in Children

This study underscores the importance of [lifestyle modifications] as the primary approach to managing [dyslipidemia] in [obese children]. Further research is essential to understand the long-term effects of statins in this population and determine appropriate guidelines for their use. Like a camel navigating the desert with a compass and map, healthcare professionals need reliable evidence to guide their treatment decisions.

Dr.Camel's Conclusion

This systematic review highlights the need for further research on the use of statins to treat dyslipidemia in obese children. While statins may be effective in other populations, more evidence is needed to understand their specific benefits and risks in obese children. Remember, the journey towards healthy lipid levels requires a multi-faceted approach – combining lifestyle modifications with evidence-based medical treatments can lead to better outcomes for children.

Date :
  1. Date Completed 2019-02-07
  2. Date Revised 2019-02-15
Further Info :

Pubmed ID

30156604

DOI: Digital Object Identifier

PMC6173338

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.